Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/04/2008US20080300263 Pyrazolo [1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
12/04/2008US20080300262 Combination Therapy for Relief of Pain
12/04/2008US20080300261 Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease
12/04/2008US20080300260 HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor)
12/04/2008US20080300259 Multimediator 5-Ht6 Receptor Antagonists, and Uses Related Thereto
12/04/2008US20080300258 Anhydrous ciprofloxacin hydrochloride
12/04/2008US20080300257 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES
12/04/2008US20080300256 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics
12/04/2008US20080300255 Substituted pyrazoles
12/04/2008US20080300254 Tylophorine Analogs as Antitumor Agents
12/04/2008US20080300253 Treatment of inflammatory disorders with praziquantel
12/04/2008US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
12/04/2008US20080300250 Acetylenyl-pyrazolo-pyrimidine derivatives
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300248 Quinazoline Derivatives, Preparation Methods and Uses Thereof
12/04/2008US20080300247 Benzimidazole Thiophene Compounds
12/04/2008US20080300246 Compounds and Compositions as Protein Kinase Inhibitors
12/04/2008US20080300245 such as pyrazolo[1,5-a]pyridine-3-carboxylic acid [2-methyl-5-(3-trifluoromethyl-benzoylamino)-phenyl]-amide, used for treating cancer, nervous sytem disorders, restenosis, crohn's disease, vision defects, liver disorders, glomerulonephritis, inflammatory bowel disease and skin disorders
12/04/2008US20080300244 Novel compounds
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300242 Imidazopyridine Kinase Inhibitors
12/04/2008US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
12/04/2008US20080300240 Pde10 inhibitors and related compositions and methods
12/04/2008US20080300239 Quinoline derivatives as pi3 kinase inhibitors
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300237 Pharmaceutically Active Diazepanes
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008US20080300235 FXR Agonists for Reducing LOX-1 Expression
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008US20080300233 Pharmaceutical Composition Comprising Simvastatin and Ezetimibe
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080300231 Antibacterial amide macrocycles VI
12/04/2008US20080300230 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
12/04/2008US20080300229 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase
12/04/2008US20080300228 Crystalline Rostafuroxin
12/04/2008US20080300227 Drugs for treating hypertension combined with hyperuricemia and/or hypercholesterolemia
12/04/2008US20080300226 Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD
12/04/2008US20080300224 Treatment of conditions relating to hormone deficiencies by administration of progestins
12/04/2008US20080300223 (20R)-2a-Methyl-19,26,27-Trinor-Vitamin D Analogs
12/04/2008US20080300222 Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300219 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
12/04/2008US20080300218 Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material
12/04/2008US20080300217 Combination Therapy with Fumaric Acid Esters for the Treatment of Autoimmune and/or Inflammatory Disorders
12/04/2008US20080300216 Dutpase Inhibitors
12/04/2008US20080300215 Prodrugs Activated by Rna-Dependent Dna-Polymerases
12/04/2008US20080300214 Compounds for the Treatment of Marihuana Dependence, Withdrawal, and Usage
12/04/2008US20080300213 Use of A3 Adenosine Receptor Agonist in Osteoarthritis Treatment
12/04/2008US20080300212 Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
12/04/2008US20080300211 Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
12/04/2008US20080300210 Method of Controlling Insects and Virus Transmission
12/04/2008US20080300209 Gene expression and pain
12/04/2008US20080300208 Isociatrate dehydrogenase and uses therof
12/04/2008US20080300207 Protein production
12/04/2008US20080300206 Alpha-Synuclein Kinase
12/04/2008US20080300205 Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
12/04/2008US20080300204 Alpha-Synuclein Antibodies and Methods Related Thereto
12/04/2008US20080300203 Stable Quantitation and Detection of Immune Response Levels with Non-Zero Background Peptides
12/04/2008US20080300202 Subtractive transgenics
12/04/2008US20080300201 Cell Cycle Arrest and Apoptosis
12/04/2008US20080300200 Therapeutic Furopyrimidines and Thienopyrimidines
12/04/2008US20080300199 Antibacterial 1,4,5-substituted aminoglycoside analogs
12/04/2008US20080300198 Olive Compositions and Methods for Treating Inflammatory Conditions
12/04/2008US20080300197 Pharmaceutical composition having virucidal and spermicidal activity
12/04/2008US20080300196 Monosaccharide derivatives
12/04/2008US20080300195 Metabolic imprinting
12/04/2008US20080300188 hybrid Fc; useful as a carrier of biologically active molecules
12/04/2008US20080300184 Transgenic tieg non-human animals
12/04/2008US20080300181 Methods of using IL-1 antagonists to treat neointimal hyperplasia
12/04/2008US20080300178 Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421
12/04/2008US20080300171 Use of Dpp-IV Inhibitor to Reduce Hypoglycemic Events
12/04/2008US20080300165 Purposeful Movement Of Human Migratory Cells Away From An Agent Source
12/04/2008US20080300164 Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299239 Inhibitor of Glucose Absorption and Method for Producing the Same
12/04/2008US20080299238 Novel abietane diterpenoid compound, and composition comprising extract of torreya nucifera, or abietane diterpenoid compounds or terpenoid compounds isolated from them for prevention and treatment of cardiovascular disease
12/04/2008US20080299237 Personal care composition with cocoa butter and dihydroxypropyl ammonium salts
12/04/2008US20080299220 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/04/2008US20080299211 Fexofenadine suspension formulation
12/04/2008US20080299209 Novel Formulations of Fat-Soluble Active Ingredients with High Biovailability
12/04/2008US20080299207 Methods and compositions for administration of oxybutynin
12/04/2008US20080299204 Dosage forms for movement disorder treatment
12/04/2008US20080299203 Solid Pharmaceutical Dosage Formulation
12/04/2008US20080299202 Controlled-Delivery System of Pharmacologically Active Substances, Preparation Process and Medical Use Thereof
12/04/2008US20080299201 Devices, methods, and systems for accessing native neurons through artificial neural mediators (anms)
12/04/2008US20080299199 Swellable Dosage Form Comprising Gellan Gum
12/04/2008US20080299197 Triple Combination Release Multi-Layered Tablet
12/04/2008US20080299196 Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
12/04/2008US20080299195 Use of ranolazine for elevated brain-type natriuretic peptide
12/04/2008US20080299193 Pharmaceutical composition comprising eszoplicone
12/04/2008US20080299190 Direct Compression Formulation and Process
12/04/2008US20080299189 Controlled release dopamine agonist compositions
12/04/2008US20080299188 Controlled release dosage forms combining immediate release and sustainted release of low-solubility drug
12/04/2008US20080299187 Substances for Reducing Occurence of Major Cardiac Events in Humans
12/04/2008US20080299186 Coatings for applying substances onto substrate carrier
12/04/2008US20080299184 diagnosing nonsmall cell lung cancer by analyzing PCDH20 gene in a lung sample; measurement of the expression level of the cancer-suppressing gene and methylation of genomic DNA
12/04/2008US20080299182 Methods and formulations for topical gene therapy
12/04/2008US20080299178 Sustained release intraocular implants and methods for preventing retinal dysfunction
12/04/2008US20080299177 Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
1 ... 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 ... 7860